|
[1]ELLIS EL, MANN DA.Clinical evidence for the regression of liver fibrosis[J].J Hepatol, 2012, 56 (5) :1171-1180.
|
|
[2]MARCELLIN P, GANE E, BUTI M, et al.Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B:A 5-year open-label follow-up study[J].Lancet, 2013, 381 (9865) :468-475.
|
|
[3]PUCHE JE, SAIMAN Y, FRIEDMAN SL.Hepatic stellate cells and liver fibrosis[J].Compr Physiol, 2013, 3 (4) :1473-1492.
|
|
[4]ZHANG DY, GOOSSENS N, GUO J, et al.A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection[J].Gut, 2016, 65 (10) :1754-1764.
|
|
[5]WREE A, EGUCHI A, MCGEOUGH MD, et al.NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice[J].Hepatology, 2014, 59 (3) :898-910.
|
|
[6]KOUI Y, KIDO T, ITO T, et al.An in vitro human liver model by ipsc-derived parenchymal and non-parenchymal cells[J].Stem Cell Rep, 2017, 9 (2) :490-498.
|
|
[7]JIANG JX, MIKAMI K, VENUGOPAL S, et al.Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways[J].J Hepatol, 2009, 51 (1) :139-148.
|
|
[8]DELEVE LD, WANG X, GUO Y.Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence[J].Hepatology, 2008, 48 (3) :920-930.
|
|
[9]XIE G, WANG X, WANG L, et al.Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats[J].Gastroenterology, 2012, 142 (4) :918-927.
|
|
[10]DING BS, CAO Z, LIS R, et al.Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis[J].Nature, 2014, 505 (7481) :97-102.
|
|
[11]WANG L, BAI G, CHEN F, et al.Human bone marrow mesenchymal stem cells (BMSCs) suppress hepatic stellate cells (HSCs) proliferation by inhibiting the ubiquitylation of p27[J].Biochem Cell Biol, 2017, 95 (6) :18-24.
|
|
[12]SONG F, XIANG YY, HUANG M, et al.Experimental study on inhibiting EMT of rabbit bile duct epithelial cells by paclitaxel chitosan membrane[J].J Kunming Med Univ, 2017, 38 (12) :5-11. (in Chinese) 宋飞, 向盈盈, 黄明, 等.紫杉醇壳聚糖缓释膜抑制兔胆管上皮细胞EMT的实验[J].昆明医科大学学报, 2017, 38 (12) :5-11.
|
|
[13]SCHWER CI, STOLL P, GOEBEL U, et al.Effects of hydrogen sulfide on rat pancreatic stellate cells[J].Pancreas, 2012, 41 (1) :74-79.
|
|
[14]OMENETTI A, YANG L, LI YX, et al.Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation[J].Lab Invest, 2007, 87 (5) :499-514.
|
|
[15]ZHAO WH, WANG YH, CONG M.Regulatory effect of transforming growth factor-βon activation of hepatic stellate cells[J].JClin Hepatol, 2016, 32 (11) :2195-2198. (in Chinese) 赵卫华, 王燕红, 丛敏.转化生长因子β对肝星状细胞活化的调控作用[J].临床肝胆病杂志, 2016, 32 (11) :2195-2198.
|
|
[16]REN CZ, HAO LS.Signal transduction involved in activation of hepatic stellate cells[J].J Clin Hepatol, 2015, 31 (3) :452-456. (in Chinese) 任昌镇, 郝礼森.肝星状细胞活化过程中的信号转导[J].临床肝胆病杂志, 2015, 31 (3) :452-456.
|
|
[17]MARRONE G, SHAH VH, GRACIASANCHO J.Sinusoidal communication in liver fibrosis and regeneration[J].J Hepatol, 2016, 65 (3) :608-617.
|
|
[18]KUROKAWA T, ZHENG YW, OHKOHCHI N.Novel functions of platelets in the liver[J].J Gastroenterol Hepatol, 2016, 31 (4) :745-751.
|
|
[19]YOSHIDA S, IKENAGA N, LIU SB, et al.Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice[J].Gastroenterology, 2014, 147 (6) :1378-1392.
|
|
[20]SONG P, ZHANG J, ZHANG Y, et al.Hepatic recruitment of CD11b+Ly6C+inflammatory monocytes promotes hepatic ischemia/reperfusion injury[J].Int J Mol Med, 2018, 41 (2) :935-945.
|
|
[21]KARLMARK KR, WEISKIRCHEN R, ZIMMERMANN HW, et al.Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis[J].Hepatology, 2009, 50 (1) :261-274.
|
|
[22]MIURA K, YANG L, VAN RN, et al.Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2[J].Am J Physiol Gastrointest Liver Physiol, 2012, 302 (11) :g1310-g1321.
|
|
[23]PRADERE JP, KLUWE J, MINICIS SD, et al.Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice[J].Hepatology, 2013, 58 (4) :1461-1473.
|
|
[24]SEKI E, DE MINICIS S, GWAK GY, et al.CCR1 and CCR5promote hepatic fibrosis in mice[J].J Clin Invest, 2009, 119 (7) :1858-1870.
|
|
[25]HEINRICHS D, BERRES ML, NELLEN A, et al.The chemokine CCL3 promotes experimental liver fibrosis in mice[J].PLo S One, 2013, 8 (6) :e66106.
|
|
[26]BERRES ML, KOENEN RR, RUELAND A, et al.Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice[J].J Clin Invest, 2010, 120 (11) :4129-4140.
|
|
[27]WENG SY, WANG XY, VIJAYAN S, et al.IL-4 receptor alpha signaling through macrophages differentially regulates liver fibrosis progression and reversal[J].EBio Medicine, 2018, 29:92-103.
|
|
[28]HOU SM, HOU CH, LIU JF.CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κBsignaling pathway in osteoarthritis synovial fibroblasts[J].Arthritis Res Ther, 2017, 19 (1) :282.
|
|
[29]AOYAMA T, INOKUCHI S, BRENNER DA, et al.CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice[J].Hepatology, 2010, 52 (4) :1390-1400.
|
|
[30]KANTARI-MIMOUN C, CASTELLS M, KLOSE R, et al.Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis[J].Hepatology, 2015, 61 (6) :2042-2055.
|
|
[31]TEDESCO D, THAPA M, GUMBER S, et al.CD4+Foxp3+Tcells promote aberrant immunoglobulin G production and maintain CD8+T-cell suppression during chronic liver disease[J].Hepatology, 2017, 65 (2) :661-677.
|
|
[32]WU J, GUO J, CAO Q, et al.Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway[J].Oncol Lett, 2017, 13 (2) :770-776.
|
|
[33]WEAVER CT, HATTON RD, MANGAN PR, et al.IL-17 family cytokines and the expanding diversity of effector T cell lineages[J].Annu Rev Immunol, 2007, 25 (25) :821-852.
|
|
[34]CACHEM FC, DIAS AS, MONTEIROC, et al.The proportion of different IL-17-producing T cell subsets is associated with liver fibrosis in chronic hepatitis C[J].Immunology, 2017, 151 (2) :546-552.
|
|
[35]RONCAROLO MG, BATTAGLIA M.Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans[J].Nat Rev Immunol, 2007, 7 (8) :585-598.
|
|
[36]SAKAKI M, HIROISHI K, BABA T, et al.Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis[J].Hepatol Res, 2008, 38 (4) :354-361.
|
|
[37]CHOU HS, HSIEH CC, YANG HR, et al.Hepatic stel ate cells regulate immune response by way of induction of myeloid suppressor cells in mice[J].Hepatology, 2011, 53 (3) :1007-1019.
|
|
[38]DANGI A, SUMPTER TL, KIMURA S, et al.Selective expansion of allogeneic regulatory T cells by hepatic stellate cells:Role of endotoxin and implications for allograft tolerance[J].JImmunol, 2012, 188 (8) :3667-3677.
|
|
[39]PENG Y, LI Y, HE Y, et al.The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis:Asystematic review[J].Expert Rev Gastroenterol Hepatol, 2018, 12 (5) :332-338.
|
|
[40]EMANUELE E, BERTONA M.Interleukin-17-targeted treatment of alcoholic liver disease[J].Hepatology, 2009, 50 (1) :329-330.
|
|
[41]JEONG WI, PARK O, GAO B.Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis[J].Gastroenterology, 2008, 134 (1) :248-258.
|
|
[42]PENG Y, YANG T, HUANG K, et al.Salvia miltiorrhiza ameliorates liver fibrosis by activating hepatic natural killer cells in vivo and in vitro[J].Front Pharmacol, 2018, 14 (1) :48-54.
|
|
[43]POCKROS PJ, JEFFERS L, AFDHAL N, et al.Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis[J].Hepatology, 2007, 45 (3) :569-578.
|
|
[44]KRIZHANOVSKY V, YON M, DICKINS RA, et al.Senescence of activated stellate cells limits liver fibrosis[J].Cell, 2008, 134 (4) :657-667.
|
|
[45]GAO B, RADAEVA S, PARK O.Liver natural killer and natural killer T cells:Iunobiology and emerging roles in liver diseases[J].J Leukoc Biol, 2009, 86 (3) :513-528.
|
|
[46]KRMER B, KRNER C, KEBSCHULL M, et al.Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis[J].Hepatology, 2012, 56 (4) :1201-1213.
|
|
[47]JEONG WI, PARK O, SUH YG, et al.Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice[J].Hepatology, 2011, 53 (4) :1342-1351.
|
|
[48]GAO B, JEONG WI, TIAN Z.Liver:An organ with predominant innate immunity[J].Hepatology, 2008, 47 (2) :729-736.
|
|
[49]BOND NG, KAUR A.NKT cells:Bridging innate and adaptive immunity[M].Encyclopedia of AIDS, 2016.
|
|
[50]WEHR A, BAECK C, HEYMANN F, et al.Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis[J].J Immunol, 2013, 190 (10) :5226-5236.
|
|
[51]JIN Z, RUI SUN, WEI H, et al.Accelerated liver fibrosis in hepatitis B virus transgenic mice:Involvement of natural killer T cells[J].Hepatology, 2011, 53 (1) :219-229.
|
|
[52]WANG H, YIN S.Natural killer T cells in liver injury, inflammation and cancer[J].Expert Rev Gastroenterol Hepatol, 2015, 9 (8) :1077-1085.
|
|
[53]CRISPE IN.The liver as a lymphoid organ[J].Annu Rev Immunol, 2009, 27 (27) :147-163.
|
|
[54]CONNOLLY MK, BEDROSIAN AS, MALLEN-ST CJ, et al.In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha[J].J Clin Invest, 2009, 119 (11) :3213-3225.
|
|
[55]COLLIN M, BIGLEY V.Human dendritic cell subsets:An update[J].Immunology, 2018, 119 (15) :301-307.
|
|
[56]THAPA M, CHINNADURAI R, VELAZQUEZ VM, et al.Liver fibrosis occurs through dysregulation of My D88-dependent innate B-cell activity[J].Hepatology, 2015, 61 (6) :2067-2079.
|
|
[57]TRAUTWEIN C, FRIEDMAN SL, SCHUPPAN D, et al.Hepatic fibrosis:Concept to treatment[J].J Hepatol, 2015, 62 (1) :s15-s24.
|
|
[58]LEE YA, WALLACE MC, FRIEDMAN SL.Pathobiology of liver fibrosis:A translational success story[J].Gut, 2015, 64 (5) :830-841.
|
DownLoad: